Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » About Us » Our Staff » Turna Ray

Turna Ray

Managing Editor, Precision Oncology News
Phone Number
+1-212-651-5626
Email
[email protected]
Turna Ray at Genomeweb / 360dx Turna Ray at Genomeweb / 360dx

Turna Ray has been covering the personalized medicine and molecular diagnostics industries for GenomeWeb since 2006. She closely tracks the evolving regulatory, reimbursement, and business environment for precision medicine products. 

Articles Authored by Turna Ray

Dec 10, 2020

Exact Sciences Oncotype DX Identifies Postmenopausal Breast Cancer Patients Who Can Forgo Chemo

Premium

The results, presented at SABCS this week, leave open whether the added benefit from chemo seen in premenopausal women may be due to chemo-induced hormone reduction.

Dec 02, 2020

Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement

Premium

The companies will work with labs to improve payors' understanding of the costs of performing PD-L1 testing and the value it provides to patient care.

Nov 12, 2020

Quest Diagnostics Win in Wrongful Death Case Reveals Ongoing Challenges for Variant Classification

Williams v Quest/Athena struck a nerve with the genetic testing community by probing what the standard of care is and ought to be for variant classification.  

Oct 14, 2020

NCI-MATCH Data Shows Value of Platform Trials for Patients With Rare Genomically Driven Cancers

Premium

The findings demonstrate the value of multi-cohort platform trials as an option for refractory cancer patients with particularly rare genomic tumor alterations.

Oct 13, 2020

Palmetto Cease-and-Desist Letter to Reimbursement Expert Raises Questions About Pricing Transparency

Premium

As government lab spending grows, the Medicare contractor has barred access to a coding and pricing file obtained via FOIA claiming it holds business secrets.

Aug 28, 2020

Stakeholders Scramble to Predict Impact of HHS Move Limiting FDA Ability to Regulate LDTs

Premium

The move raises questions about what precisely is an LDT outside of FDA jurisdiction and heightens concerns that poorly validated tests will enter the market and endanger public health.

Jun 04, 2020

Studies Show Potential of Video, Online Education to Expand Cancer Risk Genetic Test Access

Premium

The MAGENTA and ProGen trials showed that video-based and online education can increase the number of patients getting tested compared to traditional approaches.  

May 31, 2020

Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients

Two studies presented at ASCO's virtual annual meeting demonstrated the clinical utility of germline findings in guiding treatment decisions in cancer.

May 29, 2020

Patients Having Ovaries Removed Without Clear Genetic, Medical Rationale, Study Suggests

Premium

Results from the PROMPT registry presented at ASCO showed that 10 to 15 percent of women with variants in genes not linked to ovarian cancer had oophorectomies.

May 21, 2020

Q&A: ACMG Work Group Hoping to Spark Discussion on Reporting Germline Findings From Tumor Testing

In an interview, Marilyn Li and Douglas Stewart discuss why ACMG has put forth points that doctors and labs should consider when presumed germline findings crop up in tumor testing.

The Scan

Areas of Limited Testing

The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

Clouded 'Crystal Ball'

According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.

Million a Day

The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.

Science Papers Trace Drivers of Metastasis; Genetic Analysis of Stone, Bronze Age Eastern Europeans

In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.